Fidelity Investments
AGL icon

Fidelity Investments’s Agilon Health AGL Stock Holding History

Fidelity Investments’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$731K Buy
6,817
+2,780
+69% +$182K ﹤0.01% 3137
2026
Q1 		$31.9K Sell
4,037
-111,280
-96% -$1.8M ﹤0.01% 4315
2025
Q4 		$1.99M Sell
115,317
-510,516
-82% -$9.9M ﹤0.01% 2620
2025
Q3 		$16.1M Sell
625,833
-946,996
-60% -$35.8M ﹤0.01% 1818
2025
Q2 		$90.4M Buy
1,572,829
+808,910
+106% +$64.9M 0.01% 1163
2025
Q1 		$82.7M Buy
763,919
+476,130
+165% +$41.4M 0.01% 1169
2024
Q4 		$13.7M Sell
287,789
-840,781
-74% -$50.8M ﹤0.01% 1851
2024
Q3 		$111M Sell
1,128,570
-1,148,520
-50% -$148M 0.01% 1062
2024
Q2 		$372M Sell
2,277,090
-180,158
-7% -$25.7M 0.02% 557
2024
Q1 		$375M Buy
2,457,248
+25,939
+1% +$4.32M 0.03% 549
2023
Q4 		$763M Buy
2,431,309
+1
+0% +$362 0.06% 295
2023
Q3 		$1.08B Buy
2,431,308
+25
+0% +$11.3K 0.09% 192
2023
Q2 		$1.05B Buy
2,431,283
+245,014
+11% +$138M 0.09% 202
2023
Q1 		$1.3B Buy
2,186,269
+319,417
+17% +$179M 0.12% 152
2022
Q4 		$753M Buy
1,866,852
+394,532
+27% +$185M 0.07% 261
2022
Q3 		$862M Buy
1,472,320
+77,829
+6% +$46.6M 0.09% 207
2022
Q2 		$761M Buy
1,394,491
+180,480
+15% +$91.3M 0.08% 251
2022
Q1 		$769M Buy
1,214,011
+390,118
+47% +$201M 0.06% 303
2021
Q4 		$556M Buy
823,893
+371,817
+82% +$226M 0.04% 426
2021
Q3 		$296M Buy
452,076
+172,307
+62% +$147M 0.02% 644
2021
Q2 		$284M Buy
+279,769
New +$245M 0.02% 675

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fidelity Investments's AGL Position: Q2 2026 in Review

Fidelity Investments increased its Agilon Health (AGL) stake by 69% in Q2 2026, buying an estimated $182K and bringing the position to 6,817 shares worth $731K. The position accounts for ﹤0.01% of the portfolio, ranked #3137.

Fidelity Investments first reported a position in AGL in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.3B in Q1 2023. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Fidelity Investments held 6,817 shares of Agilon Health worth $731K as of Q2 2026.
  • Fidelity Investments bought 2,780 Agilon Health shares in Q2 2026, an estimated $182K.
  • Agilon Health made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3137 holding.
  • Fidelity Investments first reported a position in Agilon Health in Q2 2021 and has held it in 21 quarters since.
  • Fidelity Investments's Agilon Health position peaked at $1.3B in Q1 2023.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.